Cargando…
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations
Drug resistance in Plasmodium parasites is a constant threat. Novel therapeutics, especially new drug combinations, must be identified at a faster rate. In response to the urgent need for new antimalarial drug combinations we screened a large collection of approved and investigational drugs, tested...
Autores principales: | Mott, Bryan T., Eastman, Richard T., Guha, Rajarshi, Sherlach, Katy S., Siriwardana, Amila, Shinn, Paul, McKnight, Crystal, Michael, Sam, Lacerda-Queiroz, Norinne, Patel, Paresma R., Khine, Pwint, Sun, Hongmao, Kasbekar, Monica, Aghdam, Nima, Fontaine, Shaun D., Liu, Dongbo, Mierzwa, Tim, Mathews-Griner, Lesley A., Ferrer, Marc, Renslo, Adam R., Inglese, James, Yuan, Jing, Roepe, Paul D., Su, Xin-zhuan, Thomas, Craig J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585899/ https://www.ncbi.nlm.nih.gov/pubmed/26403635 http://dx.doi.org/10.1038/srep13891 |
Ejemplares similares
-
PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers
por: Eastman, Richard T., et al.
Publicado: (2016) -
“Drug resistance associated membrane proteins”
por: Sherlach, Katy S., et al.
Publicado: (2014) -
Plasmodium falciparum chloroquine resistance transporter (PfCRT) isoforms PH1 and PH2 perturb vacuolar physiology
por: Callaghan, Paul S., et al.
Publicado: (2016) -
Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel Structures
por: Mason, Daniel J., et al.
Publicado: (2018) -
Large-scale pharmacological profiling of 3D tumor models of cancer cells
por: Mathews Griner, Lesley A, et al.
Publicado: (2016)